<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-CAI-2210</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2437</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МАТЕРИАЛЫ ФОРУМА "ДНИ ИММУНОЛОГИИ В СПБ" 2021</subject></subj-group></article-categories><title-group><article-title>КЛИНИЧЕСКАЯ И ИММУНОЛОГИЧЕСКАЯ ЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ АМБРОЗИЙНОГО ПОЛЛИНОЗА В САМАРСКОЙ ОБЛАСТИ</article-title><trans-title-group xml:lang="en"><trans-title>CLINICAL AND IMMUNOLOGICAL EFFECTIVENESS OF TREATMENT OF RAGWEED POLLINOSIS IN THE SAMARA REGION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жукова</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhukova</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аллерголог-иммунолог, оториноларинголог, ассистент кафедры внутренних болезней, </p><p>443124, г. Самара, 6-я просека, 155, 40</p></bio><bio xml:lang="en"><p>Allergist-Immunologist, Otorhinolaryngologist, Assistant Professor, Department of Internal Diseases,</p><p>443124, Samara, 6th proseka, 155, 40</p></bio><email xlink:type="simple">natalia1807@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Манжос</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Manzhos</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., доцент, заведующая кафедрой внутренних болезней, </p><p>443124, г. Самара, 6-я просека, 155, 40</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Associate Professor, Head, Department of Internal Diseases, </p><p>443124, Samara, 6th proseka, 155, 40</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хабибулина</surname><given-names>Л. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Khabibulina</surname><given-names>L. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент кафедры морфологии и патологии, </p><p>443124, г. Самара, 6-я просека, 155, 40</p></bio><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of Morphology and Pathology,</p><p>443124, Samara, 6th proseka, 155, 40</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сырцова</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Syrtsova</surname><given-names>E. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент кафедры внутренних болезней, </p><p>443124, г. Самара, 6-я просека, 155, 40</p></bio><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of Internal Diseases, </p><p>443124, Samara, 6th proseka, 155, 40</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинский университет «Реавиз»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical University “Reaviz”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2021</year></pub-date><volume>23</volume><issue>4</issue><fpage>921</fpage><lpage>926</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Жукова Н.Н., Манжос М.В., Хабибулина Л.Р., Сырцова Е.Ю., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Жукова Н.Н., Манжос М.В., Хабибулина Л.Р., Сырцова Е.Ю.</copyright-holder><copyright-holder xml:lang="en">Zhukova N.N., Manzhos M.V., Khabibulina L.R., Syrtsova E.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2437">https://www.mimmun.ru/mimmun/article/view/2437</self-uri><abstract><p>Аллергический ринит и бронхиальная астма – широко распространенные респираторные аллергические заболевания. На некоторых территориях РФ доминирующей причиной поллиноза является амброзия. Целью исследования было оценить клиническую и иммунологическую эффективность АСИТ аллергеном Ambrosia artemisiifolia у пациентов, сенсибилизированных Ambrosia trifida в Самарской области. Пациентам с подтвержденной сенсибилизацией к амброзии трехраздельной была проведена иммунотерапия аллергоидом амброзии полыннолистной предсезонно. После лечения у пациентов было отмечено снижение степени выраженности симптомов аллергического ринита по ВАШ (p = 0,00001), снижение потребности в медикаментозных средствах (p = 0,0003), а также потребности в ГКС на фоне проводимой терапии с 34,6% до 0% (p = 0,00001). В 8% случаев результат лечения был хороший, в 69% – удовлетворительный, в 23% – неудовлетворительный. В группе контроля не было отмечено изменений степени выраженности симптомов (p = 0,858). Также в группе контроля потребность в лекарственных препаратах осталась без изменений и 14,3% пациентов продолжали использовать ГКС.</p><p>После АСИТ наблюдалось снижение уровня IL-4 (p = 0,002), и снижение соотношения IL-4/IL-10 (p = 0,0063); при этом изменения уровня остальных цитокинов (IL-10; IFNγ) оказались статистически незначимыми (p &gt; 0,05). До лечения уровни IL-4/IL-10 в обеих группах были сопоставимы, а после лечения различия стали статистически значимы (p = 0,031). Мы не получили статистически-значимого изменения уровня IgG4 Amb a 1, IgG4 Amb trifida. Зависимости (корреляции) между уровнем отдельных цитокинов и результатами лечения получено не было. В результате проведенной АСИТ были получены положительные клинические и иммунологические результаты. У большинства пациентов заболевание приобрело контролируемое течение. При этом отсутствие отличных и низкое число хороших результатов АСИТ, вероятно, связано с внутривидовыми аллергенными свойствами амброзии. </p></abstract><trans-abstract xml:lang="en"><p>Allergic rhinitis and bronchial asthma are widespread respiratory allergic diseases. In some territories of the Russian Federation, the dominant cause of pollinosis is ragweed. The aim of the study was to evaluate the clinical and immunological efficacy of ASIT with the allergen Ambrosia artemisiifolia in patients sensitized to Ambrosia trifida in the Samara region. Patients with proven sensitization to Ambrosia trifida was held immunotherapy with Ambrosia artemisiifolia allergoid preseason. After treatment, patients had a decrease in the severity of symptoms of allergic rhinitis according to VAS (p = 0.00001), a decrease in the need for medications (p = 0.0003), as well as the need for corticosteroids against the background of therapy from 34.6% to 0% (p = 0.00001). In 8% of cases, the result of treatment was good, in 69% satisfactory, in 23% unsatisfactory. In the control group, there were no changes in the severity of symptoms (p = 0.858). Also, in the control group, the need for medications remained unchanged and 14.3% of patients continued to use corticosteroids.</p><p>After ASIT, there was a decrease in the level of IL-4 (p = 0.002), and a decrease in the ratio of IL-4/ IL-10 (p = 0.0063); at the same time, changes in the level of other cytokines (IL-10; IFNγ) were statistically insignificant (p &gt; 0.05). Before treatment, the levels of IL-4/ IL-10 in both groups were comparable, and after treatment, the differences became statistically significant (p = 0.031). We did not get a statistically significant change in the level of IgG4 Amb a 1 or IgG4 Amb trifida. There was no correlation between the level of individual cytokines and the results of treatment. As a result of the conducted ASIT, positive clinical and immunological results were obtained. In most patients, the disease has acquired a controlled course. At the same time, the lack of excellent and low number of good results of ASIT is probably due to the intraspecific allergenic properties of ragweed. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>амброзия</kwd><kwd>иммунотерапия</kwd><kwd>поллиноз</kwd><kwd>трифида</kwd><kwd>цитокины</kwd><kwd>IL-4</kwd><kwd>Amb a 1</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ragweed</kwd><kwd>immunotherapy</kwd><kwd>pollinosis</kwd><kwd>trifida</kwd><kwd>cytokines</kwd><kwd>IL-4</kwd><kwd>Amb a 1</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Asero R., Weber B., Mistrello G., Amato S., Madonini E., Cromwell O. Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: analysis of the allergenic differences between short and giant ragweed. J. Allergy Clin. Immunol., 2005, Vol. 116, no. 5, pp. 1036-1041.</mixed-citation><mixed-citation xml:lang="en">Asero R., Weber B., Mistrello G., Amato S., Madonini E., Cromwell O. Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: analysis of the allergenic differences between short and giant ragweed. J. Allergy Clin. Immunol., 2005, Vol. 116, no. 5, pp. 1036-1041.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Barberi S., Villa M.P., Pajno G.B., La Penna F., Barreto M., Cardelli P., Amodeo R., Tabacco F., Caminiti L., Ciprandi G. Immune response to sublingual immunotherapy in children allergic to mites. J. Biol. Regul. Homeost. Agents, 2011, Vol. 25, no. 4, pp. 627-634.</mixed-citation><mixed-citation xml:lang="en">Barberi S., Villa M.P., Pajno G.B., La Penna F., Barreto M., Cardelli P., Amodeo R., Tabacco F., Caminiti L., Ciprandi G. Immune response to sublingual immunotherapy in children allergic to mites. J. Biol. Regul. Homeost. Agents, 2011, Vol. 25, no. 4, pp. 627-634.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bousquet P.J., Combescure C., Neukirch F., Klossek J.M., Méchin H., Daures J.P. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy, 2007, Vol. 62, no. 4, pp. 367-372.</mixed-citation><mixed-citation xml:lang="en">Bousquet P.J., Combescure C., Neukirch F., Klossek J.M., Méchin H., Daures J.P. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy, 2007, Vol. 62, no. 4, pp. 367-372.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chen K.W., Marusciac L., Tamas P.T., Valenta R., Panaitescu C. Ragweed pollen allergy: burden, characteristics, and management of an imported allergen source in europe. Int. Arch. Allergy Immunol., 2018, Vol. 176, no. 3-4, pp. 163-180.</mixed-citation><mixed-citation xml:lang="en">Chen K.W., Marusciac L., Tamas P.T., Valenta R., Panaitescu C. Ragweed pollen allergy: burden, characteristics, and management of an imported allergen source in europe. Int. Arch. Allergy Immunol., 2018, Vol. 176, no. 3-4, pp. 163-180.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chuchalin A.G., Khaltaev N., Antonov N.S, Galkin D.V., Manakov L.G., Antonini P. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. Chron. Obstruct. Pulmon. Dis., 2014, Vol. 12, pp. 963-974.</mixed-citation><mixed-citation xml:lang="en">Chuchalin A.G., Khaltaev N., Antonov N.S, Galkin D.V., Manakov L.G., Antonini P. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. Chron. Obstruct. Pulmon. Dis., 2014, Vol. 12, pp. 963-974.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorov A.S., Litvinova L.S., But-Gusaim V.I., Litvinenko S.N. Allergen-specific immunotherapy: vaccines for allergic diseases. Medical Immunology (Russia), 2015, Vol. 17, no. 5, pp. 407-422. (In Russ.) doi:10.15789/1563-0625-2015-5-407-422-422.</mixed-citation><mixed-citation xml:lang="en">Fedorov A.S., Litvinova L.S., But-Gusaim V.I., Litvinenko S.N. Allergen-specific immunotherapy: vaccines for allergic diseases. Medical Immunology (Russia), 2015, Vol. 17, no. 5, pp. 407-422. (In Russ.) doi:10.15789/1563-0625-2015-5-407-422-422.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gushchin I.S. Prevention of allergic imminence. Russian Pulmonology Journal, 2010, no. 4, pp. 23-33. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Gushchin I.S. Prevention of allergic imminence. Russian Pulmonology Journal, 2010, no. 4, pp. 23-33. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ilyina N.I., Luss L.V., Kurbacheva O.M., Nazarova E.V., Pavlova K.S. The influence of climatic factors on the spectrum and structure of allergic diseases on the case of the Moscow region. Russian Journal of Allergy, 2014, no. 2, pp. 25-31. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Ilyina N.I., Luss L.V., Kurbacheva O.M., Nazarova E.V., Pavlova K.S. The influence of climatic factors on the spectrum and structure of allergic diseases on the case of the Moscow region. Russian Journal of Allergy, 2014, no. 2, pp. 25-31. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pfaar O., Demoly P., Gerth van Wijk R., Bonini S., Bousquet J., Canonica G.W., Durham S.R., Jacobsen L., Malling H.J., Mösges R., Papadopoulos N.G., Rak S., Rodriguez del Rio P., Valovirta E., Wahn U., Calderon M.A., European Academy of Allergy and Clinical Immunology. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy, 2014, Vol. 69, no. 7, pp. 854-867.</mixed-citation><mixed-citation xml:lang="en">Pfaar O., Demoly P., Gerth van Wijk R., Bonini S., Bousquet J., Canonica G.W., Durham S.R., Jacobsen L., Malling H.J., Mösges R., Papadopoulos N.G., Rak S., Rodriguez del Rio P., Valovirta E., Wahn U., Calderon M.A., European Academy of Allergy and Clinical Immunology. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy, 2014, Vol. 69, no. 7, pp. 854-867.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Potter P.C., Baker S., Fenemore B., Nurse B. Clinical and cytokine responses to house dust mite sublingual immunotherapy. Ann. Allergy Asthma Immunol., 2015, Vol. 114, no. 4, pp. 327-334.</mixed-citation><mixed-citation xml:lang="en">Potter P.C., Baker S., Fenemore B., Nurse B. Clinical and cytokine responses to house dust mite sublingual immunotherapy. Ann. Allergy Asthma Immunol., 2015, Vol. 114, no. 4, pp. 327-334.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Shahbaz S. K., Varasteh A.R., Koushki K., Ayati S.H., Mashayekhi K., Sadeghi M., Moghadam M., Sankian M.. Sublingual dendritic cells targeting by aptamer: Possible approach for improvement of sublingual immunotherapy efficacy. Int. Immunopharmacol., 2020, Vol. 85, 106603. doi: 10.1016/j.intimp.2020.106603.</mixed-citation><mixed-citation xml:lang="en">Shahbaz S. K., Varasteh A.R., Koushki K., Ayati S.H., Mashayekhi K., Sadeghi M., Moghadam M., Sankian M.. Sublingual dendritic cells targeting by aptamer: Possible approach for improvement of sublingual immunotherapy efficacy. Int. Immunopharmacol., 2020, Vol. 85, 106603. doi: 10.1016/j.intimp.2020.106603.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Z.H., Gao Z.H., Xue J.M., Wang X.S., Song M.T. The efficacy of sublingual immunotherapy for allergic rhinitis and the predictive role of cytokines in its therapeutic effect. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2019, Vol. 33, no. 4, pp. 332-336. (In Chin.)</mixed-citation><mixed-citation xml:lang="en">Sun Z.H., Gao Z.H., Xue J.M., Wang X.S., Song M.T. The efficacy of sublingual immunotherapy for allergic rhinitis and the predictive role of cytokines in its therapeutic effect. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2019, Vol. 33, no. 4, pp. 332-336. (In Chin.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ukhanova O.P., Bogdanova M.A., Zheltova I.V., Yudin A.A., Shcherbinin F.A. Aeropalynological monitoring of weed pollen and mold spores. Russian Medical Review, 2020, Vol. 4, no.1, pp. 48-51. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Ukhanova O.P., Bogdanova M.A., Zheltova I.V., Yudin A.A., Shcherbinin F.A. Aeropalynological monitoring of weed pollen and mold spores. Russian Medical Review, 2020, Vol. 4, no.1, pp. 48-51. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Würtzen P.A., Hoof I., Christensen L.H., Váczy Z., Henmar H., Salamanca G., Lundegaard C., Lund L., Kráľova T., Brooks E.G , Andersen P.S. Diverse and highly cross-reactive T-cell responses in ragweed allergic patients independent of geographical region. Allergy, 2020, Vol. 75, no. 1, pp. 137-147.</mixed-citation><mixed-citation xml:lang="en">Würtzen P.A., Hoof I., Christensen L.H., Váczy Z., Henmar H., Salamanca G., Lundegaard C., Lund L., Kráľova T., Brooks E.G , Andersen P.S. Diverse and highly cross-reactive T-cell responses in ragweed allergic patients independent of geographical region. Allergy, 2020, Vol. 75, no. 1, pp. 137-147.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhukova N.N., Manzhos M.V., Seleznev A.V. Examining sIgE-profile in patients with ambrosia allergy in Samara. Russian Journal of Immunology, 2020, Vol. 23, no. 4, pp. 473-478. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Zhukova N.N., Manzhos M.V., Seleznev A.V. Examining sIgE-profile in patients with ambrosia allergy in Samara. Russian Journal of Immunology, 2020, Vol. 23, no. 4, pp. 473-478. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
